HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

GYKI 52466

an AMPA (non-NMDA) receptor antagonist; structure given in first source
Also Known As:
1-(p-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine hydrochloride; GYKI-52466; Benzenamine, 4-(8-methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)-
Networked: 76 relevant articles (12 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kerr, D Steven: 2 articles (07/2015 - 01/2010)
2. Levay, Gyorgy: 2 articles (09/2005 - 05/2004)
3. Kleinrok, Z: 2 articles (11/2001 - 03/2001)
4. Nayak, Prasanta K: 1 article (07/2015)
5. Rzeski, Wojciech: 1 article (02/2014)
6. Trojanowski, Tomasz: 1 article (02/2014)
7. Stoma, Filip: 1 article (02/2014)
8. Deneka-Hannemann, Sylwia: 1 article (02/2014)
9. Walczak, Katarzyna: 1 article (02/2014)
10. Jarosz, Bo┼╝ena: 1 article (02/2014)

Related Diseases

1. Seizures (Seizure)
2. Ischemia
3. Brain Injuries (Brain Injury)
4. Infarction
5. Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)

Related Drugs and Biologics

1. alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)
2. N-Methylaspartate (NMDA)
3. 2,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)
4. Dizocilpine Maleate (Dizocilpine)
5. Excitatory Amino Acid Antagonists
6. Kainic Acid (Kainate)
7. AMPA Receptors (AMPA Receptor)
8. Kainic Acid Receptors (Kainate Receptor)
9. GYKI 53655
10. N-Methyl-D-Aspartate Receptors (NMDA Receptors)

Related Therapies and Procedures

1. Aftercare (After-Treatment)